Literature DB >> 9541776

Perception of motherese in Japanese sign language by 6-month-old hearing infants.

N Masataka1.   

Abstract

N. Masataka (1996) reported results of an experiment in which 6-month-old deaf infants were presented with videotapes that showed 5 identical scripts signed in Japanese Sign Language by 5 deaf mothers toward their deaf infants or toward their deaf friends. The experiment demonstrated that infants showed greater attentional and affective responsiveness to infant-directed signing than to adult-directed signing. The present study explored the possibility that this same phenomenon might extend to hearing infants who have never been exposed to signed language. When the same stimulus tape as used previously was presented to 45 six-month-old hearing infants, they too showed greater attentional and affective responsiveness to infant-directed sign than to adult-directed sign. This fact suggests that infants are prepared to detect sign motherese characteristics without specific experience in the modality.

Entities:  

Mesh:

Year:  1998        PMID: 9541776     DOI: 10.1037//0012-1649.34.2.241

Source DB:  PubMed          Journal:  Dev Psychol        ISSN: 0012-1649


  4 in total

1.  Discriminating signs: perceptual precursors to acquiring a visual-gestural language.

Authors:  Makeba Parramore Wilbourn; Marianella Casasola
Journal:  Infant Behav Dev       Date:  2006-09-15

2.  Detecting 'infant-directedness' in face and voice.

Authors:  Hojin I Kim; Scott P Johnson
Journal:  Dev Sci       Date:  2014-02-27

3.  Infant-Directed Visual Prosody: Mothers' Head Movements and Speech Acoustics.

Authors:  Nicholas A Smith; Heather L Strader
Journal:  Interact Stud       Date:  2014

Review 4.  Motherese in interaction: at the cross-road of emotion and cognition? (A systematic review).

Authors:  Catherine Saint-Georges; Mohamed Chetouani; Raquel Cassel; Fabio Apicella; Ammar Mahdhaoui; Filippo Muratori; Marie-Christine Laznik; David Cohen
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.